Peripheral Nerve Stimulators Market is segmented By Product Type (Implant, Percutaneous), By End-User (Hospitals, Ambulatory Surgical Centers, Others)....
Market Size in USD
CAGR4.9%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 4.9% |
Market Concentration | High |
Major Players | B. Braun Melsungen AG, Bioventus, AVNS, Nalu Medical Inc., Stimwave LLC |
The peripheral nerve stimulators market is estimated to be valued at USD 0.68 Bn in 2024 and is expected to reach USD 1.09 Bn by 2031, growing at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.
The peripheral nerve stimulators market is expected to witness a positive growth trend over the forecast period. The major factor driving the growth of the market includes the rising prevalence of neuropathic pain and other chronic pain disorders. Neuropathic pain arises due to the damage or dysfunction of the somatosensory nervous system and usually requires long term treatment options. Peripheral nerve stimulators are emerging as an effective therapeutic modality for relieving various types of neuropathic pain. Their advantages over traditional pain therapies such as reduced systemic side effects, non-invasiveness and customizable therapy are expected to support the increasing adoption of these devices.